Interpretation of 2024 ESC guidelines for the management of elevated blood pressure and hypertension
- VernacularTitle:《2024年ESC血压升高和高血压管理指南》解读
- Author:
Yu CHENG
1
,
2
;
Yiheng ZHOU
1
,
2
;
Yao LÜ
1
,
2
;
Dongze LI
3
;
Lidi LIU
1
,
2
;
Peng ZHANG
1
,
2
;
Rong YANG
1
,
2
;
Yu JIA
1
,
2
;
Rui ZENG
4
;
Zhi WAN
3
;
Xiaoyang LIAO
1
,
2
Author Information
1. 1. General Practice Ward/ International Medical Center Ward, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China 2. Teaching &
2. Research Section, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China 3.General Practice Medical Center and General Practice Research Institute, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
3. 4. Emergency Department/Emergency Medicine Laboratory, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China 5. Disaster Medicine Center, Sichuan University, Chengdu, 610041, P. R. China
4. Department of Cardiology, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
- Publication Type:Journal Article
- Keywords:
European Society of Cardiology (ESC);
elevated blood pressure;
hypertension;
guidelines interpretation
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2025;32(01):31-40
- CountryChina
- Language:Chinese
-
Abstract:
The European Society of Cardiology (ESC) released the "2024 ESC guidelines for the management of elevated blood pressure and hypertension" on August 30, 2024. This guideline updates the 2018 "Guidelines for the management of arterial hypertension." One notable update is the introduction of the concept of "elevated blood pressure" (120-139/70-89 mm Hg). Additionally, a new systolic blood pressure target range of 120-129 mm Hg has been proposed for most patients receiving antihypertensive treatment. The guideline also includes numerous additions or revisions in areas such as non-pharmacological interventions and device-based treatments for hypertension. This article interprets the guideline's recommendations on definition and classification of elevated blood pressure and hypertension, and cardiovascular disease risk assessment, diagnosing hypertension and investigating underlying causes, preventing and treating elevated blood pressure and hypertension. We provide a comparison interpretation with the 2018 "Guidelines for the management of arterial hypertension" and the "2017 ACC/AHA guideline on the prevention, detection, evaluation, and management of high blood pressure in adults."
